Myomo
21 hedge funds and large institutions have $3.09M invested in Myomo in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 4 closing their positions.
1.12% less ownership
Funds ownership: 27.42% → 26.3% (-1.1%)
5% less funds holding
Funds holding: 22 → 21 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
57% less capital invested
Capital invested by funds: $7.2M → $3.09M (-$4.11M)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Top Buyers
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$75.9K |
| 2 |
Renaissance Technologies
New York
|
+$64.1K |
| 3 |
VF
Virtu Financial
New York
|
+$38.3K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$157 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$10 |
Top Sellers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$330K |
| 2 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$114K |
| 3 |
MOS
MGO One Seven
Beachwood,
Ohio
|
-$40K |
| 4 |
BlackRock
New York
|
-$37.7K |
| 5 |
JP Morgan Chase
New York
|
-$4.3K |
MYO Hedge Fund Activity: Q2 2022 in Review
21 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Myomo (MYO) for Q2 2022, worth a combined $3.09M — down 57% from $7.2M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of MYO and 3 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 2 added.
The largest buyer was Bridgeway Capital Management, adding an estimated $75.9K. The largest seller was Ameriprise, exiting entirely with an estimated $330K sold.
- 21 institutional investors held Myomo (MYO) as of Q2 2022, down from 22 in Q1 2022.
- Funds reported $3.09M of Myomo stock for Q2 2022, down 57% quarter-over-quarter.
- 3 funds opened new Myomo positions in Q2 2022 and 4 closed out, a net change of -1 holder.
- The largest Myomo buyer in Q2 2022 was Bridgeway Capital Management, an estimated $75.9K added.
- The largest Myomo seller in Q2 2022 was Ameriprise, an estimated $330K sold.
Based on aggregated 13F filings for Q2 2022.